ECRM_1170x120_1-10-22

Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott

PCMA issue statement on the 2023 Medicare Part D proposed rule

PCMA issue statement on the 2023 Medicare Part D proposed rule

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the 2023 Medicare Part D proposed rule from the Centers for Medicare & Medicaid Services (CMS): “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they would significantly increase Medicare

PCMA issues statement on drug pricing agreement in the budget bill

PCMA issues statement on drug pricing agreement in the budget bill

WASHINGTON — Pharmaceutical Care Management Association (PCMA) Ppresident and CEO JC Scott issued the following statement on Congress’ agreement on drug pricing language for the budget bill: “We appreciate congressional negotiators’ focus on prescription drug prices and applaud inclusion of repeal of the rebate rule, a rule which threatens to dramatically increase premiums for Medicare

PCMA: Senator Braun’s proposed infrastructure amendment hurts seniors, increases taxpayer costs

PCMA: Senator Braun’s proposed infrastructure amendment hurts seniors, increases taxpayer costs

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the proposed amendment by Senator Mike Braun (R, Ind.) in the Bipartisan Infrastructure Framework (BIF) legislation: “The Senate’s inclusion of a provision to delay the Medicare rebate rule in the infrastructure legislation is a good start to full

PCMA announces Virtual PBM Policy Forum 2021

PCMA announces Virtual PBM Policy Forum 2021

WASHINGTON — Today, the Pharmaceutical Care Management Association (PCMA) announced the Virtual PBM Policy Forum 2021, featuring health care, pharmacy benefit managers (PBMs), and pharmaceutical manufacturer industry thought leaders and executives discussing how the public and private sectors are tackling drug costs and improving the affordability and quality of care for patients. “We are pleased

PCMA: Drug manufacturers’ pricing tactics reduce competition, increase Rx drug costs

PCMA: Drug manufacturers’ pricing tactics reduce competition, increase Rx drug costs

WASHINGTON — As the House Committee on Oversight and Reform continues its investigation into drug manufacturers’ pricing strategies, the Pharmaceutical Care Management Association (PCMA) is releasing new data on the impact of blocking competition for top-selling medications. Brand-name drug manufacturers use “patent thickets” to block generic or biosimilar competition from entering the market. For Humira, Enbrel,

PCMA unveils three-part policy platform to reduce prescription drug costs

PCMA unveils three-part policy platform to reduce prescription drug costs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing a new three-part policy platform, supported by America’s pharmacy benefit managers, PBMs, aimed at reducing prescription drug costs by updating Medicare Part D, enhancing competition, and building toward a more value-driven health care system for patients. “PCMA’s multi-faceted policy platform provides specific policy actions to

PCMA praises Biden Administration’s nominees for key Department of HHS positions

PCMA praises Biden Administration’s nominees for key Department of HHS positions

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the pending confirmations of three officials of the U.S. Department of Health and Human Services (HHS): Chiquita Brooks-LaSure, nominee for Administrator for the Centers for Medicare & Medicaid Services; Andrea Palm, nominee for Deputy Secretary; Melanie Egorin, nominee

Number of independent pharmacies in U.S. increasing

Number of independent pharmacies in U.S. increasing

WASHINGTON — The number of independent pharmacies in the United States increased in 2020, according to a new analysis of pharmacy data. Pharmacy data from the National Council for Prescription Drug Programs, analyzed by the healthcare analytics firm Quest Analytics, shows the overall number of independent pharmacy stores increased by 449 between January 2020 and

PCMA intros new campaign aimed at repealing the Medicare prescription drug rebate rule

PCMA intros new campaign aimed at repealing the Medicare prescription drug rebate rule

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) unveiled a new campaign commending the Biden Administration for delaying the Medicare prescription drug rebate rule, while calling for a complete Congressional repeal. “We applaud the Biden Administration for delaying the rebate rule’s effective date in order to further examine the rule’s impact on Medicare beneficiaries,” said

Study: Powerful PSAOs negotiate on behalf of independent pharmacies

Study: Powerful PSAOs negotiate on behalf of independent pharmacies

WASHINGTON — A new report, “Pharmacy Services Administrative Organizations (PSAOs) and their Little-Known Connection to Independent Pharmacies,” sheds light on the role of PSAOs in the prescription drug supply and payment chain. The white paper, researched and written by the health care policy consulting firm Health Evaluations and released by the Pharmaceutical Care Management Association

PCMA statement on Senate Finance Committee insulin report

PCMA statement on Senate Finance Committee insulin report

WASHINGTON – The Pharmaceutical Care Management Association (PCMA) released the following statement on the Senate Finance Committee’s report on insulin pricing: “We appreciate the Senate Finance Committee’s focus on insulin pricing and share their urgency in addressing affordability and access for insulin-dependent patients. While we are reviewing the committee’s findings, it’s important to understand that

PCMA Federal Policy Priorities: 21 policies to reduce prescription drug costs in 2021

PCMA Federal Policy Priorities: 21 policies to reduce prescription drug costs in 2021

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with health coverage through employers, health insurers, labor unions, Medicare and Medicaid. PBMs are the

PCMA files lawsuit challenging rebate rule

PCMA files lawsuit challenging rebate rule

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) today filed a lawsuit challenging the Trump Administration’s rebate rule. PCMA’s lawsuit, filed in the district court for the District of Columbia, asks the court to set aside the rebate rule under the Administrative Procedure Act. The PCMA lawsuit also includes a request for a declaration from the

PCMA welcomes new staff member, announces new roles

PCMA welcomes new staff member, announces new roles

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of Michael Power as senior director, State Affairs and new roles for Tim Dube, Melodie Shrader, Heather Cascone, and Randy Kane. Michael Power joins PCMA with a long list of association state advocacy work in the Southeastern U.S. He brings experience and many